Compass Therapeutics, Inc. (CMPX)
|Net Income (ttm)||-27.12M|
Cambridge, Massachusetts-based Compass was founded to develop antibody approaches to treating cancers as a monotherapy and in combination with existing approved drugs, including Her2+ breast c...
Compass Therapeutics Inc., the Massachusetts-based biopharmaceutical company focused on cancer treatments, has filed to go public.
Compass Therapeutics, Inc. has filed to go public with an IPO on the NASDAQ stock exchange.
Compass Therapeutics is a clinical-stage biopharmaceutical company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. Our immuno-oncology product candidates include a clinical-stage monoclonal antibody and a portfolio of bispecific antibodies. These product candidates are designed to address three critical components required for an effective immune response to cancer: induction of a potent innate immune response; activation of the adaptive immune system; ... [Read more...]
|IPO Date |
Thomas J. Schuetz
|Stock Exchange |
|Ticker Symbol |